Stock BWAY BRAINSWAY LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials BrainsWay Ltd.

Equities

BWAY

IL0011007189

Advanced Medical Equipment & Technology

Market Closed - TEL AVIV STOCK EXCHANGE
Other stock markets
 07:24:09 2024-04-25 am EDT 		5-day change 1st Jan Change
954.3 ILa -1.91% Intraday chart for BrainsWay Ltd. -0.59% -16.95%
Apr. 17 Brainsway Expands Deep Tms Access in Israel Following Significant Increase in Reimbursement Rates CI
Apr. 04 BrainsWay Ltd. Announces Publish Review Results Highlighting Potential of Deep Transcranial Magnetic Stimulation (Deep TMS?) as a Novel Therapeutic Approach for Parkinson's Disease CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 108.3 79.07 128.1 33.45 105.2 83.45 - -
Enterprise Value (EV) 1 108.3 79.07 128.1 33.45 105.2 83.45 83.45 83.45
P/E ratio - - - - - - - -
Yield - - - - - - - -
Capitalization / Revenue 4.69 x 3.58 x 4.32 x 1.23 x 3.31 x 2.21 x 1.9 x 1.67 x
EV / Revenue 4.69 x 3.58 x 4.32 x 1.23 x 3.31 x 2.21 x 1.9 x 1.67 x
EV / EBITDA -19,072,146 x -36,778,120 x - - - - - -
EV / FCF - -20,243,973 x - - - - - -
FCF Yield - -0% - - - - - -
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 22,236 22,251 32,904 32,960 33,082 33,274 - -
Reference price 2 16.81 11.42 12.09 3.563 11.49 9.543 9.543 9.543
Announcement Date 3/23/20 3/24/21 3/9/22 3/15/23 3/6/24 - - -
1ILS in Million2
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 23.1 22.06 29.66 27.18 31.78 37.78 44.04 49.84
EBITDA -5.681 -2.15 - - - - - -
EBIT 1 -8.476 -4.829 -4.999 -12.68 -4.107 -0.1325 2.882 -
Operating Margin -36.69% -21.89% -16.86% -46.67% -12.92% -0.35% 6.55% -
Earnings before Tax (EBT) 1 -9.906 -5.148 -6.419 -13.03 -3.946 -0.3433 1.784 -
Net income 1 -10.33 -5.385 -6.462 -13.35 -4.197 -0.672 2.281 -
Net margin -44.71% -24.41% -21.79% -49.12% -13.2% -1.78% 5.18% -
EPS - - - - - - - -
Free Cash Flow - -3.906 - - - - - -
FCF margin - -17.71% - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 3/23/20 3/24/21 3/9/22 3/15/23 3/6/24 - - -
1USD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 8.061 8.47 7.97 8.006 5.168 6.033 6.625 7.829 8.302 9.029 8.72 9.223 9.6 10.23 10.78
EBITDA - - - - - - - - - - - - - - -
EBIT 1 -1.233 -1.452 -1.482 -2.008 -4.87 -4.323 -3.667 -1.343 -0.133 0.184 -0.4648 -0.1665 0.1272 0.3712 0.26
Operating Margin -15.3% -17.14% -18.59% -25.08% -94.23% -71.66% -55.35% -17.15% -1.6% 2.04% -5.33% -1.81% 1.33% 3.63% 2.41%
Earnings before Tax (EBT) 1 -1.593 -1.831 -1.806 -2.337 -4.969 -3.922 -2.26 -1.478 -0.171 -0.037 -0.4097 -0.132 0.0163 0.1817 -
Net income 1 -1.804 -1.347 -1.993 -2.45 -5.039 -3.867 -2.431 -1.663 -0.23 0.127 -0.5615 -0.286 -0.011 0.2112 0.06
Net margin -22.38% -15.9% -25.01% -30.6% -97.5% -64.1% -36.69% -21.24% -2.77% 1.41% -6.44% -3.1% -0.11% 2.06% 0.56%
EPS - - - - - - - - - - - - - - -
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/17/21 3/9/22 5/11/22 8/10/22 11/16/22 3/15/23 5/17/23 8/9/23 11/15/23 3/6/24 - - - - -
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - -3.91 - - - - - -
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 - 2.47 2.24 - - - - -
Capex / Sales - 11.2% 7.55% - - - - -
Announcement Date 3/23/20 3/24/21 3/9/22 3/15/23 3/6/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
BRAINSWAY LTD. Stock BrainsWay Ltd.
-16.95% 83.26M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.07% 219B
DANAHER CORPORATION Stock Danaher Corporation
+6.59% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.26% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.57% 108B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.65% 63.06B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.35% 52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.62% 48.2B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.93% 40.37B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+11.54% 39.35B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. BWAY Stock
  4. Financials BrainsWay Ltd.